The Research
Department I
Cardiac Development and RemodellingProf. Dr. Dr. Thomas Braun
Department II
PharmacologyProf. Dr. Stefan Offermanns
Department III
Developmental GeneticsDr. Didier Stainier
Department IV
Lung Development and RemodellingProf. Dr. Werner Seeger
Information for
Log on
Structure and Development of the Alveolus

Principal Investigator:
Dr. Rory E. Morty
The Morty Laboratory has two major research themes, both of which relate directly to adult and neonatal critical care medicine.
Alveoloar ion and fluid transport

- Figure 1
Alveolar ion and fluid transport are critically impaired in mechanically ventilated patients with acute lung injury (ALI), or in its severest form, acute respiratory distress syndrome (ARDS), leading to pulmonary oedema (see figure 1), and death.
This syndrome is responsible for a high proportion of patient deaths in the adult intensive care unit. Members of the Morty Laboratory investigate the mechanisms of how ions and water are normally transported into and out of the lung, and what happens when these mechanisms fail in patients with pulmonary oedema.
The studies are aiming to obtain a better understanding of the molecular mechanisms underlying the development of ARDS, and so establish better management strategies for patients with this devastating syndrome.
Normal late lung development

- Figure 2
One of the aims of normal lung development is to maximise the total surface area available in the lung for gas exchange, and to reduce the distance between the blood circulation and the lung/air interface, to allow for effective transport of oxygen into the bloodstream, and carbon dioxide out of the bloodstream.
In humans, lung development proceeds until at least seven years of age, and possibly longer. How the lung is programmed to achieve this is currently unknown. Lung development is initiated with the separation of the primitive respiratory system from the gut and the branching of the bronchi (early lung development), and later, the development of the alveoli - the functional gas exchange units of the lung (late lung development). This process is illustrated schematically in figure 2.
Members of the Morty Laboratory are currently exploring the genetic mechanisms which drive the process of septation, where alveolar walls divide to generate large numbers of alveoli, as well as how blood vessels form and grow, to support the developmnet of the alveolar structures.
Pathological late lung development

- Figure 3
Late lung developmnet is dangerously impacted when infants are born prematurely. These infants are ventilated to support life (see figure 3). However, this ventilation process is very damaging to the lung and can cause bronchopulmonary dysplasia (BPD). In this case the alveolar structure is perturbed in affected patients, with consequences that extend into adulthood.
Members of the Morty Laboratory are currently exploring what goes wrong, when premature infants are ventilated and develop BPD, with the aim to develop new ways to clinically manage this complex and important clinical problem encountered in the neonatal intensive care unit.
Group Members
Doctoral Students:
Technical Assistant:
About Rory E. Morty
Dr. Rory E. Morty is appointed as full-time research scientist in the Department of Lung Development and Remodelling at the Max Planck Institute for Heart and Lung Research in Bad Nauheim, where he serves as Principal Investigator, leading the research group "Structure and Development of the Alveolus". Dr. Morty is also appointed at the Department of Internal Medicine (Pulmonology) at the University of Giessen School of Medicine, where he serves as Director of the International Graduate Programme "Molecular Biology and Medicine of the Lung", coordinator of the University of Giessen and Marburg Lung Center School, and together with Professor Jürgen Lohmeyer (Department of Infectious Diseases), as area leader: "Barrier integrity during inflammation and repair" within the Excellence Cluster Cardio Pulmonary System
Dr. Morty was born in South Africaand completed his undergraduate and post-graduate education at the University of Natal in South Africa. This was followed by a four-year post-doctoral stay at Yale University School of Medicine. Dr Morty joined the Faculty of the University of Giessen in 2002, and the Max Planck Institute for Heart and Lung Research in 2010. Dr Morty serves as Associate Editor of the American Journal of Physiology (from 2012) and PLoS ONE (since 2007), and on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine (since 2009). Some of Dr Morty's research interests are detailed below, and are also described in the Max-Planck Society Yearbook 2011
Contact:
Wissenschaftliche Forschergruppe
Max Planck Institute for Heart and Lung Research
Parkstr. 1
61231 Bad Nauheim, Germany
Tel.: +49 (0) 6032 705-271 (office)
Fax: +49 (0) 6032 705-471
Assistant:
Monika Haselbauer
Tel.: +49(6032)705-249
Fax.: +49(6032)705-471

